Search Results for 'gemcitabine cisplatin'
-
Search Results
-
Hi everyone,
I tried to sign up on the forums last year but didn’t have success. Had hoped to be able to turn my back on Cholangiocarcinoma at the end of 2020 but here I am.
I’m a 39 year old man in Australia and my father has CCA at age 69. He was first diagnosed last July at age 68 by sheer fluke. He has previously had an enlarged (benign) prostate and therefore has regular tests. Our family GP actually picked up that dad’s liver enzymes were elevated and ordered further exploration.
The family didn’t get too worried until we heard the dreaded C word for the first time and then googled it. What nightmares are made of, right?
When further exploration was done, it was found that tumours were in the left side of the liver, with some lymph node activity. He was absolutely borderline with regard to having a resection as an option. He responded famously to chemotherapy (apart from his veins in his arm regularly collapsing and hurting) which was the commonly prescribed gemcitabine and cisplatin (3 weeks on, 2 weeks off from memory).
In November 2020 he was given the go ahead for a resection. Around 75% of his liver was removed and 12 lymph nodes. The surgeon could barely find evidence of the cancer in his liver (still performed the op as planned), and cancer was detected in one lymph node. He had a few rounds of chemo afterward to be on the safe side. No complications from surgery etc.
Christmas and the first half of 2021 was fantastic, given we had received the best possible news that there was no evidence of cancer, despite the qualification that CCA is notorious for coming back.
Fast forward to one year almost to the week, after his first diagnosis, and dad has elevated liver enzymes again.
Exploration was undertaken and a stricture was found in the bile duct. The pathology company came back with a “no cancer – scar tissue” result – the surgeon disagreed and ordered another pathologist to investigate – who came back and said microscopic evidence of cancer was in the scar tissue (very concerning of the pathologist to mess that up – wonder how often that happens).
Anyway a stent was inserted into the bile duct during that procedure, and over the last few weeks the surgeons and oncologists have been meeting.
This week, after deliberation, they have undertaken RFA as the cancer appeared to be under 3cm in length, and chemo will follow. Unfortunately as many medical specialists have a tendency to do, they delivered matter of fact news to him to say the RFA went as planned but is no way a cure, and that he will likely need it every 3 months and chemo regularly for the rest of his life. “Palliative care” was mentioned, which has really shaken dad, my mum (69yo), sister (41yo) and me. This diagnosis is being referred to as synchronous not recurrent.
Reports I have read, show that RFA has positive outcomes, I’ll hang onto that for now.
We aren’t going to give up hope, and I’ll keep you updated. We just hope he responds well to the chemo again, and if we had a few more years with him, and he has them with us and his 4 grandchildren with a decent quality of life, who knows what drugs may come out etc.
I’ve raised Keytruda with his oncologist a few times and it’s been considered but dismissed. Will keep looking into other options and trials. I do wonder about it still.
The worst part is that my dad looks 50, is otherwise extremely fit and healthy, and has a really wonderful family and life. It’s just not fair is it.
Anyway, of potential interest to others – we have always been told that CCA is not hereditary however, my dad’s first cousin was battling CCA for 3 years, unfortunately losing it earlier this year (which also makes it hard for dad to be optimistic). Dad and his cousin have lived in different states in Australia for their whole lives, which rules out anything environmental. There has to be a genetic link. This cancer is so rare, it would be an amazing coincidence if not.
Dad and other family members have the BRCA2 gene mutation, which dramatically increases the risk of cancers mainly in women (breast, ovarian etc.) but I do wonder if years from now we will see a common link between BRCA2 and CCA. Our family is currently undergoing genetic testing to determine who else has the faulty gene. Im waiting on the results myself which is nerve wracking.
I guess we all just have to be thankful every day we wake up. The thing which tears me apart is seeing how flat my mum and dad are. I am a problem solver and whenever there is an issue in my family, I like to find a solution. This situation is one which I can’t let defeat me, but keeping hopes and spirits up for others is a difficult thing to do when I am mourning and fearful of losing my dad myself, and my mum losing her soulmate.
I’m hoping this forum will give me a bit of a place to talk.
Anyway, that’s me and that’s our predicament. Very familiar for many of you I am sure.
Keep fighting,
Nick x
Hi all,
Please see the below thread and I just wanted to put a link to this in the chemo thread as well.
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary
Thanks all,
Gavin
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract CancersA Phase 2 Clinical Trial
Thanks to JAMA Network for this piece.
Gavin
Hi everyone,
I am new to this website and hopefully can learn from you.
My wife was diagnosed with ICC last month in Australia and doctor told us it’s unresectable. It was like a nightmare as she is only 39 years old and our kid is in kindergarten. Doctor advised my wife to join a clinical trial (Pembrolizumab Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma). Not sure if this is the best option for us? My wife has 50% chance of being treated with Pembrolizumab. Has someone been treated with Pembrolizumab and how did it work ? My wife needs to do some tests before she can start the treatment which is probably the end of this month.
Thanks for this website. I find it very useful.
Combination of HAI-FUDR and Systemic Gemcitabine and Cisplatin in Unresectable Cholangiocarcinoma: A Dose Finding Single Center Study
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers
Feasibility and efficacy evaluation of metallic biliary stents eluting gemcitabine and cisplatin for extrahepatic cholangiocarcinoma
Cisplatin and Gemcitabine Chemotherapy and Lenvatinib for Patients With Unresectable Intrahepatic Cholangiocarcinoma
https://www.clinicaltrials.gov/ct2/show/NCT04527679
GDC-0980 (apitolisib) treatment with gemcitabine and/or cisplatin synergistically reduces cholangiocarcinoma cell growth by suppressing the PI3K/Akt/mTOR pathway
Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements